Our study examined the modulation of MDR1 and MRP3 gene expression in NSCLC cancer cell lines treated with plasma concentrations of Pac and Car in order to understand the resistance mechanism against these drugs. The gene discussed is ABCC3; the disease is non-small cell lung carcinoma.